Real-time enrollment status for this leukemia, myeloid, chronic clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:47 AM UTC
| NCT Number | NCT04260022 |
| Recruiting Status | Recruiting |
| Condition | Leukemia, Myeloid, Chronic |
| Phase | Clinical Trial |
| Target Enrollment | 242 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Ascentage Pharma Group Inc. |
| Last Updated on CT.gov | November 5, 2025 (Nov 5, 2025) |
As of July 13, 2026: Clinical trial NCT04260022 is currently recruiting participants. This clinical trial study for leukemia, myeloid, chronic is actively seeking new participants at 8 locations across the United States. The study is sponsored by Ascentage Pharma Group Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04260022 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04260022 was last updated Nov 5, 2025 (November 5, 2025). HelloStudys verifies this status automatically.